Election 2014
SENSEX NIFTY

Drug Company

Apr 15, 2014 at 17:51 | Source: CNBC-TV18
The pharma company had licensed out the drug, GBR 500, to Sanofi and had received an upfront payment of USD 50 million dollars from the French drugmaker in 2012.
Apr 07, 2014 at 11:21 | Source: Reuters
Daiichi Sankyo said Ranbaxy shareholders will get 0.8 Sun Pharma shares for each Ranbaxy share. The merged company will also become the largest drug firm in India.
Apr 07, 2014 at 09:09 | Source: Moneycontrol.com
Aarti Drugs has appointed Shri Prakash M. Patil, Managing Director (MD) as the Chairman of the Company.
Apr 07, 2014 at 08:29 | Source: CNBC-TV18
Former Ranbaxy chairman and CEO Malvinder Singh blamed Daiichi Sankyo for what he claimed to be the Japanese drug majors failure to build on the Indian companys intrinsic value.
Apr 04, 2014 at 13:26 | Source: Moneycontrol.com
Pan Drugs has informed that Mr. Arvind Narharibhai Brahmbhatt, the Manager - Corporate Compliance is also appointed as Compliance Officer of the Company, in addition to Mr. Pradeep J. Shah.
Mar 31, 2014 at 10:31 | Source: Moneycontrol.com
Parenteral Drugs India has informed that the production at the newly established plant of Punjab Formulations Limited, a subsidiary of the Company, situated at Village Ahirana, Dist. Hoshiarpur, Punjab is starting on March 28, 2014.
Mar 27, 2014 at 18:59 | Source: PTI
The company's product is the generic equivalent of Pfizer Inc's Caduet tablets, it added. The Hyderabad-based firm's Amlodipine Besylate and Atorvastatin Calcium tablets are available in bottle counts of 30 and 90, the company said.
Mar 24, 2014 at 21:08 | Source: Moneycontrol.com
Trimurthi Drugs & Pharmaceuticals at its meeting held on March 24, 2014, has considered and approved the operations of the Company. Investment of Rs. 29,50,000 in M/s. Trimurthi Pharmaceuticals (India) Private Limited towards subscription of equity shares.
Mar 21, 2014 at 23:16 | Source: Moneycontrol.com
Trimurthi Drugs & Pharmaceuticals board meeting will be held on March 24, 2014, to transact and consider the review of operations of the Company and to consider the investment in similar pharma company.
Mar 18, 2014 at 23:04 | Source: Moneycontrol.com
Parenteral Drugs India has informed that the proposed resignation of Mr. Yogesh Khakre from the post of Company Secretary and Compliance Officer of the Company w.e.f. March 01, 2014 has been approved by the management of the Company on March 18, 2014.
Messages on Drug Company »

OrthoDoc

New Member

5 Followers

Aurobindo Pharm  

...so buy , rather accumulate Auro even at current levels for a 1-2 year timeframe. these US legalities are nothing new to Indian drug companies,happens all the time !

10.06 AM Apr 17th

Web Messenger

Platinum Member

208645 Followers

Sun Pharma  

Source:VC Circle - Sun Pharmaceutical Industries Ltd, the country's top drugmaker by market cap, is acquiring Ranbaxy Laboratories Ltd in an all-stock transaction, creating the world's fifth-largest generics drug company and the largest pharma company in India by far

12.10 PM Apr 8th

tubes

Platinum Member

58 Followers

Sun Pharma  

Is it patent dispute with Drug company UCB?

9.16 PM Mar 18th

bhagyodayat
rust

Gold Member

8 Followers

Vivimed Labs  

I am doctor by profession and knows the value of research and upcoming drugs. COMPANY has spent lot of rs in research and next quarter filing new ADNA / molecules which will drive the earning. you see almost 90% of shares are by institutes or large investor.

12.47 PM Mar 18th

Web Messenger

Platinum Member

208645 Followers

Cipla  

Source:Calcutta Telegraph News - Mumbai, Feb. 20: Cipla has entered into an agreement with MSD to market the latter’s anti-HIV drug raltegravir in the country. This is the first time that Cipla is entering into a strategic partnership with a multinational drug company. MSD is the trade name

2.10 PM Feb 21st

mylo

Platinum Member

125 Followers

Wockhardt  

comes at a time when India-based drug companies, including Ranbaxy and Wockhardt, are reeling under the heat of the US regulator’s scrutiny. The visit is to strengthen cooperation between the US regulator and its Indian counterparts, the FDA said, adding that Hamburg is scheduled to meet Indian policy

5.54 PM Feb 9th

jagishar

Platinum Member

492 Followers

Just Posted  

on India," said a drug company executive. Reuters says PhRMA plans to submit to the US government by the Friday filing deadline a list of concerns about countries they believe could be a part of the Special 301 Report, an annual message from the Office of the United States Trade Representative. Despite

10.35 AM Feb 7th

Dr Reddys Labs  

in new opportunities for the drug companies which will cast a negative reflection in the growth and profitability of these companies. - My target for Dr Reddys Labs is Rs 1800 for the short term

10.35 AM Feb 3rd

Dr Reddys Labs  

in new opportunities for the drug companies which will cast a negative reflection in the growth and profitability of these companies. - My target for Dr Reddys Labs is Rs 1800 for the short term

10.46 AM Jan 30th

Sun Pharma  

in new opportunities for the drug companies which will cast a negative reflection in the growth and profitability of these companies.

1.54 PM Jan 29th

Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.